Data&Drinks - Biotech Startups: Insights and Lessons Learned
When starting a new Biotech as a Founder, Venture Capitalist, or Founding member, there are lots of questions and challenges to tackle such as:
-Who should I be partnering with?
-What roles must be kept internal?
-How can I put myself in the best place for future funding?
-What technology solutions should I have in place, and when?
Please join us for Collaborative Drug Discovery's (CDD) Data&Drinks on October 15, 2025 at Princeton Innovation Center BioLabs while we enjoy an evening of drinks, hors d'oeuvres, and an exciting discussion on the topics above by our esteemed panelists.
What to Expect
Networking & Drinks
Connect with industry peers, trade lessons learned, and explore collaborations over libations and appetizers.45-minute Actionable Panel Discussion with Experts
Gain real-world insights from existing startup founders and VC organizationsRomyr Dominique will be joined by 3 key leaders in the space:
Arnie Levine - Founder of PMV Pharma
Ariane Vasilatis - Founder and CEO and Eileen Carry - Co-Founder and CSO of Zena Therapeutics
Jonathan Baell - CSO of Manas AI
Sponsors
Collaborative Drug Discovery (CDD) offers CDD Vault, a comprehensive, web-based informatics platform for managing and analyzing chemical and biological data. Designed to facilitate secure collaboration among researchers globally, CDD Vault supports the entire drug discovery process, enabling efficient data capture, analysis, and sharing. The Vault platform helps streamline research efforts, optimize decision-making, and accelerate the path from discovery to development in the pharmaceutical and biotech industries.
Reach out to Jacqueline Macia to learn more
Princeton Innovation Center BioLabs whose mission is to foster innovation, collaboration and entrepreneurship—in essence, to create and grow an innovation ecosystem—by supporting early-stage startups with high potential. Our mission is aligned with, and intended to further, Princeton University’s educational mission and the societal benefits of commercializing transformative technology. We understand the key challenges and pain-points science startups face. Our goal is to change how you do business by building an ecosystem that empowers entrepreneurial scientists to grow quickly, while maximizing capital efficiency.
Reach out to Michelle Roemer Schoen to learn more